Omega 3 fatty acids for the treatment of dementia (Q24187713)

2

0 references

Tobias Wustmann

3

0 references

Stefan Watzke

4

0 references

Gero Langer

5

0 references

Astrid Fink

Cochrane Database of Systematic Reviews

6

0 references

publication date

10 March 2015

0 references

published in

0 references

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Why US adults use dietary supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Dietary and lifestyle guidelines for the prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Omega-3 fatty acids for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Omega-3 fatty acids and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Consumer usage and reasons for using dietary supplements: report of a series of surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

GRADE guidelines: 2. Framing the question and deciding on important outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Omega 3 fatty acids for prevention and treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

New insights into the dementia epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

The role for dietary omega-3 fatty acids supplementation in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Dietary fat composition and dementia risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Associations between serum cholesterol levels and cerebral amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Malnutrition and dementia in the elderly in German nursing homes. Results of a prevalence survey from the years 2008 and 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Malnutrition in community-dwelling adults with dementia (NutriAlz Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

What is the clinically relevant change on the ADAS-Cog?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Omega 3 fatty acid for the prevention of cognitive decline and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Endpoints for trials in Alzheimer's disease: a European task force consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

Omega 3 fatty acids for the treatment of dementia and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Distribution, interconversion, and dose response of n-3 fatty acids in humans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009002.PUB2